[HTML][HTML] Carbohydrate conjugates in vaccine developments
S Lang, X Huang - Frontiers in Chemistry, 2020 - frontiersin.org
Vaccines are powerful tools that can activate the immune system for protection against
various diseases. As carbohydrates can play important roles in immune recognition, they …
various diseases. As carbohydrates can play important roles in immune recognition, they …
[HTML][HTML] Antimicrobial peptides and cationic nanoparticles: a broad-spectrum weapon to fight multi-drug resistance not only in bacteria
GE Valenti, S Alfei, D Caviglia, C Domenicotti… - International journal of …, 2022 - mdpi.com
In the last few years, antibiotic resistance and, analogously, anticancer drug resistance have
increased considerably, becoming one of the main public health problems. For this reason, it …
increased considerably, becoming one of the main public health problems. For this reason, it …
Immunoliposomes in clinical oncology: State of the art and future perspectives
Liposomal formulations entrapping a vast number of molecules have improved cancer
therapies overcoming certain pharmacokinetic (PK) and pharmacodynamic limitations, many …
therapies overcoming certain pharmacokinetic (PK) and pharmacodynamic limitations, many …
Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity
L Gkionis, RA Campbell, H Aojula, LK Harris… - International journal of …, 2020 - Elsevier
Developing more efficient manufacturing methods for nano therapeutic systems is becoming
important, not only to better control their physico-chemical characteristics and therapeutic …
important, not only to better control their physico-chemical characteristics and therapeutic …
Folic acid-modified curcumin-loaded liposomes for breast cancer therapy
MT Luiz, JAP Dutra, T de Cássia Ribeiro… - Colloids and Surfaces A …, 2022 - Elsevier
Breast cancer is the commonest cancer among women, with more than 2 million cases per
year and a lethality rate of 17.7%. The treatment of breast cancer still being a challenge due …
year and a lethality rate of 17.7%. The treatment of breast cancer still being a challenge due …
Application of stem cells in regeneration medicine
Y Jin, S Li, Q Yu, T Chen, D Liu - MedComm, 2023 - Wiley Online Library
Regeneration is a complex process affected by many elements independent or combined,
including inflammation, proliferation, and tissue remodeling. Stem cells is a class of primitive …
including inflammation, proliferation, and tissue remodeling. Stem cells is a class of primitive …
[HTML][HTML] MiR-124 and the underlying therapeutic promise of neurodegenerative disorders
D Han, X Dong, D Zheng, J Nao - Frontiers in pharmacology, 2020 - frontiersin.org
Neurodegenerative disorders (NDDs) are a group of chronic progressive neurological
diseases based on primary neurodegeneration. The common pathological characteristics of …
diseases based on primary neurodegeneration. The common pathological characteristics of …
[HTML][HTML] Lactoferrin: A nutraceutical with activity against colorectal cancer
G Ramírez-Rico, ME Drago-Serrano… - Frontiers in …, 2022 - frontiersin.org
Homeostasis in the human body results from the tight regulation of several events, since too
little inflammation disrupts the process of tissue repair and remodeling, whereas too much …
little inflammation disrupts the process of tissue repair and remodeling, whereas too much …
Peptide-based nanovaccines in the treatment of cervical cancer: a review of recent advances
J Zhang, J Fan, M Skwarczynski… - International Journal …, 2022 - Taylor & Francis
Persistent infection with high-risk human papillomaviruses (HPVs), such as HPV-16 and
HPV-18, can induce cervical cancer in humans. The disease carries high morbidity and …
HPV-18, can induce cervical cancer in humans. The disease carries high morbidity and …
[HTML][HTML] Progress on the application of bortezomib and bortezomib-based nanoformulations
J Liu, R Zhao, X Jiang, Z Li, B Zhang - Biomolecules, 2021 - mdpi.com
Bortezomib (BTZ) is the first proteasome inhibitor approved by the Food and Drug
Administration. It can bind to the amino acid residues of the 26S proteasome, thereby …
Administration. It can bind to the amino acid residues of the 26S proteasome, thereby …